A new study based on Danish data indicates that GLP-1 medications could help reduce long-term sick leave. According to the findings, individuals taking GLP-1 drugs experienced 17 percent fewer long-term absences from work.
The research highlights a potential broader workplace and economic impact tied to the use of these medications. By decreasing extended periods of employee absence, the drugs may offer tangible health and productivity benefits for workforce populations.
In-depth summary · AI, neutral